Srikem Laboratories

What Srikem Laboratories does

Srikem Laboratories Pvt. Ltd., founded in 1994 by Mr. Srinivasan, is a Mumbai-headquartered pharmaceutical company that manufactures, packs, and supplies Active Pharmaceutical Ingredients (APIs) and excipients to pharmaceutical manufacturers globally. The company operates a single multi-purpose organic synthesis manufacturing facility at MIDC Taloja, Navi Mumbai, producing a portfolio of 20+ APIs spanning antihistamines (Hydroxyzine, Meclizine, Cyclizine, Buclizine, Flunarizine and others), antifungals (Bifonazole, Clotrimazole), NSAIDs (Diclofenac Diethylamine), dermatological agents (Tretinoin, Permethrin, Silver Sulphadiazine, Monobenzone), an antiviral (Umifenovir), a hematinic (Iron Poly Sucrose), and the excipient Sodium Stearyl Fumarate. Products are manufactured to BP, EP, USP, IP, INH, and JP pharmacopeial standards under cGMP and ICH Q7 compliance, with FDA-recognized quality systems. A DSIR-approved R&D facility supports new molecule development and custom/toll manufacturing.

The business model is direct B2B sales of catalog APIs to pharmaceutical companies, with the company holding approved-vendor status for the top 10 pharmaceutical companies in India and distributing to customers in 40+ countries. Pricing is not publicly disclosed; transactions are initiated through a website product enquiry form routed to [email protected]. The company generates revenue from a single revenue stream — manufacture and sale of APIs and excipients — with no licensing, royalty, or service-line diversification disclosed. Customer segmentation is horizontal across the pharmaceutical industry, anchored to large enterprise buyers rather than long-tail volume customers.

Operationally, Srikem is founder-led, privately held, and employs 51-100 people across three Mumbai-area locations (head office in Chembur, registered office in Chunabhatti, and the Taloja manufacturing plant). The company has no disclosed external investors, no M&A activity, and no public listing. The competitive position rests on regulatory compliance, accumulated process know-how in organic synthesis, and approved-vendor relationships with major Indian generic manufacturers; however, the absence of disclosed revenue, customer concentration data, and headcount growth signals limits visibility into commercial scale and trajectory.

Name

Srikem Laboratories

Legal name

Srikem Laboratories Pvt. Ltd.

Website

https://srikem.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

Srikem Laboratories is a Mumbai-based pharmaceutical manufacturer founded in 1994 that produces Active Pharmaceutical Ingredients (APIs) and excipients at its MIDC Taloja plant, supplying approved-vendor APIs to top pharmaceutical companies in India and customers across 40+ countries under cGMP and ICH Q7 standards.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (APIs)

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Small-Molecule API Process Development & Route Scouting (HLAGAHAA), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

Keywords

• Active pharmaceutical ingredients
• API manufacturing
• Organic synthesis manufacturing
• Pharmaceutical excipients
• Custom API development

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (APIs) Manufacturing and Sales: Srikem Laboratories generates revenue through the manufacture and sale of Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies worldwide. The company supplies APIs for various therapeutic categories including antihistamines, antifungals, NSAIDs, and dermatological products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Srikem Laboratories manufactures and supplies Active Pharmaceutical Ingredients (APIs) and select excipients to pharmaceutical companies globally. The company operates a multi-purpose organic synthesis plant in MIDC Taloja, Navi Mumbai, and offers a portfolio of 20+ APIs spanning antihistamines, antifungals, NSAIDs, retinoids/dermatologicals, antivirals, hematinics, and respiratory/GI agents, all produced under cGMP conditions per ICH Q7 guidelines. Beyond catalog APIs, the firm provides custom molecule development and toll manufacturing services from its DSIR-approved R&D facility.

Product overview

Srikem Laboratories is a trusted source of Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies worldwide. Founded in 1994, the company offers a portfolio of over 20+ active pharmaceutical ingredients and excipients. The product portfolio includes antihistamines (Hydroxyzine HCL, Hydroxyzine Pamoate, Thonzylamine HCL, Chlorcyclizine HCL, Cyclizine HCL, Cyclizine Base, Meclizine HCL, Meclizine Base, Meclozine, Clocinizine HCL, Buclizine HCL, Flunarizine HCL, Chlophedianol HCL), antifungals (Bifonazole, Clotrimazole), NSAIDs (Diclofenac Diethylamine), dermatologicals (Tretinoin, Permethrin, Silver Sulphadiazine, Monobenzone), respiratory/GI agents (Buzepide), hematinics (Iron Poly Sucrose), and excipients (Sodium Stearyl Fumarate). The company also offers Umifenovir as an antiviral API. All products are manufactured in compliance with cGMP and meet various international pharmacopeial standards including BP, EP, USP, IP, INH, and JP.

Differentiator

Problem solved

Functional benefit

Products and services

• Iron Poly Sucrose (INH) Active Pharmaceutical Ingredient (hematinic) indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD); supplied to pharmaceutical formulation manufacturers.
• Buzepide (INH) Active Pharmaceutical Ingredient (Buzepide Methiodide) used for respiratory tract disorders and gastro-intestinal disorders with smooth muscle spasm; supplied to pharmaceutical formulation manufacturers.
• Monobenzone (USP) Active Pharmaceutical Ingredient (monobenzyl ether of hydroquinone) used medically for depigmentation in vitiligo; supplied to pharmaceutical formulation manufacturers.
• Hydroxyzine Pamoate (USP) Active Pharmaceutical Ingredient (antihistamine) used for allergy treatment; supplied to pharmaceutical formulation manufacturers.
• Thonzylamine HCL (INH) Active Pharmaceutical Ingredient (antihistamine) used for symptomatic control of allergic rhinitis and other upper respiratory allergic symptoms; supplied to pharmaceutical formulation manufacturers.
• Bifonazole (BP/EP/JP) Active Pharmaceutical Ingredient (imidazole antifungal) used to treat topical fungal and yeast infections such as athlete's foot, ringworm, and itching; supplied to pharmaceutical formulation manufacturers.
• Silver Sulphadiazine (USP) Active Pharmaceutical Ingredient (sulfa-derivative topical antibacterial) used primarily on second- and third-degree burns; supplied to pharmaceutical formulation manufacturers.
• Chlorcyclizine HCL (BP) Active Pharmaceutical Ingredient (first-generation phenylpiperazine-class antihistamine) used to treat urticaria, rhinitis, pruritus, and other allergy symptoms; supplied to pharmaceutical formulation manufacturers.
• Cyclizine HCL (BP/EP) Active Pharmaceutical Ingredient (piperazine-derivative antihistamine) used in the treatment of drug-induced (postoperative) vomiting, migraine, and motion sickness; supplied to pharmaceutical formulation manufacturers.
• Cyclizine Base (BP/EP) Active Pharmaceutical Ingredient (piperazine-derivative antihistamine) used in the treatment of drug-induced (postoperative) vomiting, migraine, and motion sickness; supplied to pharmaceutical formulation manufacturers.
• Meclizine Base (INH) Active Pharmaceutical Ingredient (histamine H1 antagonist) used in the treatment of nausea, vertigo, and motion sickness; supplied to pharmaceutical formulation manufacturers.
• Meclizine HCL (USP) Active Pharmaceutical Ingredient (histamine H1 antagonist) used in the treatment of nausea, vertigo, and motion sickness; supplied to pharmaceutical formulation manufacturers.
• Meclozine (EP/BP) Active Pharmaceutical Ingredient (histamine H1 antagonist) used in the treatment of nausea, vertigo, and motion sickness; supplied to pharmaceutical formulation manufacturers.
• Tretinoin (USP) Active Pharmaceutical Ingredient (Vitamin A derivative retinoid) used to treat acne and photodamaged skin, and used as a differentiating agent in the treatment of Acute Promyelocytic Leukemia (APL); supplied to pharmaceutical formulation manufacturers.
• Permethrin (INH) Active Pharmaceutical Ingredient (pyrethroid insecticide) used in the treatment of lice infestations and scabies; supplied to pharmaceutical formulation manufacturers for medical and veterinary use.
• Clotrimazole (BP/EP/IP/USP) Active Pharmaceutical Ingredient (antifungal) used to treat skin infections and fungal infections such as itching, ringworm, athlete's foot, and Pityriasis; supplied to pharmaceutical formulation manufacturers.
• Diclofenac Diethylamine (BP/EP) Active Pharmaceutical Ingredient (acetic-acid-class NSAID) with analgesic and antipyretic properties used for acute and chronic treatment of osteoarthritis and rheumatoid arthritis; supplied to pharmaceutical formulation manufacturers.
• Hydroxyzine HCL (BP/EP/USP) Active Pharmaceutical Ingredient (antihistamine) used in the treatment of chronic urticaria, dermatitis, histamine-mediated pruritus, nausea and vomiting, and as an anxiolytic; supplied to pharmaceutical formulation manufacturers.
• Clocinizine HCL (INH) Active Pharmaceutical Ingredient (antihistamine) for use in allergic conditions; supplied to pharmaceutical formulation manufacturers.
• Buclizine HCL (BP/EP) Active Pharmaceutical Ingredient used in the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness and in the management of vertigo; supplied to pharmaceutical formulation manufacturers.
• Sodium Stearyl Fumarate (BP/USP) Excipient (inert, hydrophilic tablet lubricant) used in tablet formulations where other lubricating agents fail to provide adequate stability, hardness, content uniformity, disintegration, and dissolution rate; supplied to pharmaceutical formulation manufacturers.
• Chlophedianol HCL (INH) Active Pharmaceutical Ingredient (antitussive) used in the treatment of dry cough; supplied to pharmaceutical formulation manufacturers.
• Flunarizine HCL (BP/EP) Active Pharmaceutical Ingredient used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in epilepsy therapy; supplied to pharmaceutical formulation manufacturers.
• Umifenovir Active Pharmaceutical Ingredient (antiviral) used for the treatment of influenza and other respiratory viruses; supplied to pharmaceutical formulation manufacturers.
• Custom API and Toll Manufacturing Services Custom molecule development and toll manufacturing services for APIs and excipients, leveraging Srikem's DSIR-approved R&D facility and multi-purpose organic synthesis plant; offered to pharmaceutical customers needing specialized or proprietary API production.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Granules India: Indian manufacturer of APIs, intermediates, and finished dosages serving global generic-pharma customers. Comparable on B2B API supply model, multi-pharmacopeial compliance, and export-driven revenue mix.
• Hikal Limited: Indian API and intermediates manufacturer with multi-purpose plants, government-recognized R&D, and B2B supply to global pharma. Comparable on size band, custom synthesis capability, and regulated-market compliance posture.
• Aarti Drugs: Indian API manufacturer with overlapping therapeutic categories including antihistamines, antifungals, NSAIDs, and dermatological actives. Closely comparable on business model (B2B API supply to generic pharma), scale band, and India-based multi-purpose manufacturing footprint.
• Ipca Laboratories: Vertically integrated Indian pharma company with a meaningful API manufacturing business alongside formulations. Overlaps with Srikem on antihistamine and anti-malarial/antiemetic APIs and on multi-pharmacopeial (BP/EP/USP) exports.
• Solara Active Pharma Sciences: India-based pure-play API manufacturer with multi-pharmacopeial filings and exports to regulated markets. Closely comparable as a privately-styled, India-headquartered, B2B-focused API peer serving global generic-pharma customers.
• Meghmani Organics: Indian manufacturer of APIs and intermediates supplying domestic and global generic-pharma customers. Comparable on B2B API business model, multi-purpose plant operations, and therapeutic-area overlap including dermatological and anti-infective actives.

Regional players

• Sequent Scientific: Indian API manufacturer with focus on veterinary and dermatological actives including permethrin — a product category that overlaps with Srikem's permethrin offering. Comparable on niche-API strategy and multi-purpose plant operations.

Broad incumbents

• Divi's Laboratories: Leading Indian custom synthesis and API manufacturer supplying global pharma, with strong regulatory compliance (USFDA, EDQM). Comparable on multi-purpose organic synthesis facilities, DSIR/government-recognized R&D, and export orientation to regulated markets.
• Aurobindo Pharma: One of India's largest API and finished-dose manufacturers, with a broad small-molecule API portfolio including antihistamines, antifungals, NSAIDs, and dermatological APIs that directly overlap Srikem's product categories. A relevant comparison point on scale, regulatory depth, and global reach.

Emerging players

• Sai Life Sciences: Indian contract development and manufacturing organization (CDMO) offering custom synthesis and API manufacturing with strong R&D infrastructure. Comparable on DSIR-style R&D positioning and toll/custom-manufacturing capabilities that compete for similar customer wallets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/srikem-laboratories-pvt-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Srikem Laboratories